Additionally, a previous case report showed that pembrolizumab produced complete remission in metastatic G-CSF-producing bladder cancer [18], and another report demonstrated that G-CSF-producing lung cancers express high levels of PD-L1, which supports our interpretation [19]. This evidence concerns the gene CSF3 and urinary bladder carcinoma.